# First-generation OTC Antihistamine Use and Voice Function: A Preliminary Study

> **NCT05858216** · EARLY_PHASE1 · COMPLETED · sponsor: **Auburn University** · enrollment: 8 (actual)

## Conditions studied

- Voice Disorder Due to Iatrogenic Factor

## Interventions

- **DRUG:** Chlor-Trimeton.

## Key facts

- **NCT ID:** NCT05858216
- **Lead sponsor:** Auburn University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-13
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-04-23
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05858216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05858216, "First-generation OTC Antihistamine Use and Voice Function: A Preliminary Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05858216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*